DK1115862T3 - Cytokinreceptor Zalpha11 - Google Patents

Cytokinreceptor Zalpha11

Info

Publication number
DK1115862T3
DK1115862T3 DK99952948T DK99952948T DK1115862T3 DK 1115862 T3 DK1115862 T3 DK 1115862T3 DK 99952948 T DK99952948 T DK 99952948T DK 99952948 T DK99952948 T DK 99952948T DK 1115862 T3 DK1115862 T3 DK 1115862T3
Authority
DK
Denmark
Prior art keywords
cytokine receptor
receptor zalpha11
zalpha11
cytokine
receptor
Prior art date
Application number
DK99952948T
Other languages
Danish (da)
English (en)
Inventor
Scott R Presnell
Darrell C Conklin
Julia E Novak
Angela K Hammond
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1115862T3 publication Critical patent/DK1115862T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99952948T 1998-09-23 1999-09-23 Cytokinreceptor Zalpha11 DK1115862T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15925498A 1998-09-23 1998-09-23
US26511799A 1999-03-09 1999-03-09
US34793099A 1999-07-06 1999-07-06
PCT/US1999/022149 WO2000017235A2 (en) 1998-09-23 1999-09-23 Cytokine receptor zalpha11

Publications (1)

Publication Number Publication Date
DK1115862T3 true DK1115862T3 (da) 2009-11-16

Family

ID=27388288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99952948T DK1115862T3 (da) 1998-09-23 1999-09-23 Cytokinreceptor Zalpha11

Country Status (18)

Country Link
EP (2) EP2105446B1 (ru)
JP (2) JP4704565B2 (ru)
KR (1) KR20010085838A (ru)
CN (1) CN1344320A (ru)
AU (1) AU772172B2 (ru)
BR (1) BR9913942A (ru)
CA (1) CA2343839C (ru)
CZ (1) CZ20011026A3 (ru)
DE (1) DE69941126D1 (ru)
DK (1) DK1115862T3 (ru)
EA (3) EA014417B1 (ru)
ES (1) ES2329741T3 (ru)
HU (1) HUP0103593A2 (ru)
IL (3) IL142164A0 (ru)
NO (1) NO20011460L (ru)
NZ (1) NZ510744A (ru)
PL (1) PL349068A1 (ru)
WO (1) WO2000017235A2 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US6576744B1 (en) 1998-09-23 2003-06-10 Zymogenetics, Inc. Cytokine receptor zalpha11
US6803451B2 (en) 1998-09-23 2004-10-12 Zymogenetics, Inc. Cytokine receptor zalpha11 polypeptides
ATE456654T1 (de) 2000-04-05 2010-02-15 Zymogenetics Inc Löslicher zytokinrezeptor zalpfa11
CN1320611A (zh) * 2000-04-27 2001-11-07 上海博德基因开发有限公司 一种新的多肽——细胞因子受体15和编码这种多肽的多核苷酸
WO2001085792A2 (en) * 2000-05-11 2001-11-15 Genetics Institute, Llc. Mu-1, member of the cytokine receptor family
JP4619580B2 (ja) * 2001-07-30 2011-01-26 デンカ生研株式会社 抗体捕捉法による抗体の免疫学的測定方法
ES2629395T3 (es) * 2001-10-04 2017-08-09 Genetics Institute, Llc Métodos y composiciones para modular la actividad de la interleucina-21
ES2381265T3 (es) 2002-06-07 2012-05-24 Zymogenetics, Inc. Uso de IL-21 y anticuerpo monoclonal para tratar cánceres sólidos
WO2004003156A2 (en) 2002-07-01 2004-01-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Il-21 as a regulator of immunoglobin production
US7314623B2 (en) 2002-07-15 2008-01-01 Wyeth Methods and compositions for modulating T helper (Th) cell development and function
JP4914209B2 (ja) 2003-03-14 2012-04-11 ワイス ヒトil−21受容体に対する抗体および該抗体の使用
WO2013169693A1 (en) 2012-05-09 2013-11-14 Bristol-Myers Squibb Company Methods of treating cancer using an il-21 polypeptide and an anti-pd-1 antibody
GB201810181D0 (en) * 2018-06-21 2018-08-08 Immetacyte Ltd Cells expressing chimeric recominant growth factor receptors

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE54046B1 (en) 1981-08-25 1989-05-24 Celltech Ltd Expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
DE3578435D1 (de) 1984-12-06 1990-08-02 Labofina Sa Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
DE68926888T2 (de) 1988-01-22 1997-01-09 Zymogenetics Inc Verfahren zur Herstellung von sekretierten Rezeptoranalogen
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
NL9002116A (nl) 1990-09-27 1992-04-16 Clovis Matton N V Werkwijze voor het genetisch manipuleren van plantecellen, recombinante plasmiden, recombinante bacterien, planten.
AU647566B2 (en) 1990-12-13 1994-03-24 Immunex Corporation Leukemia inhibitory factor receptors
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
JPH08502646A (ja) 1992-09-14 1996-03-26 ファイザー・インコーポレイテッド 不死化細胞およびその使用
AU696991B2 (en) * 1993-07-16 1998-09-24 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
AU7477394A (en) 1993-07-30 1995-03-27 University Of Medicine And Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
CA2169190A1 (en) 1994-02-14 1995-08-17 Richard D. Holly Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
DK0781095T3 (da) * 1994-08-02 2003-06-23 Gen Hospital Corp Celler der bærer CD4 lokkeduereceptorer og beslægtede molekyler og fremgangsmåder
DK0871495T3 (da) * 1995-02-24 2005-10-17 Gen Hospital Corp Omdirigering af cellulær immunitet med receptorkimærer
EP0889966A1 (en) 1995-11-09 1999-01-13 ZymoGenetics, Inc. Compositions and methods for producing heterologous polypeptides in pichia methanolica
CN1238806A (zh) 1996-07-17 1999-12-15 津莫吉尼蒂克斯公司 甲醇毕赤酵母营养突变体的制备
CA2261151C (en) 1996-07-17 2003-09-16 Zymogenetics, Inc. Transformation of pichia methanolica
WO1998031811A1 (en) * 1997-01-16 1998-07-23 Genetics Institute, Inc. Member of the hematopoietin receptor superfamily
US6057128A (en) * 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
CA2330547A1 (en) * 1998-06-24 1999-12-29 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor proteins
AU5104799A (en) * 1998-08-04 2000-02-28 Regeneron Pharmaceuticals, Inc. Novel orphan cytokine receptors

Also Published As

Publication number Publication date
CA2343839C (en) 2012-09-11
CA2343839A1 (en) 2000-03-30
EP1115862B1 (en) 2009-07-15
EP2105446A3 (en) 2010-07-07
BR9913942A (pt) 2001-10-16
IL185764A (en) 2010-06-16
JP2011015700A (ja) 2011-01-27
IL185764A0 (en) 2008-01-06
WO2000017235A3 (en) 2000-07-20
EP1115862A2 (en) 2001-07-18
WO2000017235A2 (en) 2000-03-30
NZ510744A (en) 2003-02-28
AU6499899A (en) 2000-04-10
EA201001190A1 (ru) 2011-04-29
EP2105446A2 (en) 2009-09-30
CZ20011026A3 (cs) 2001-08-15
EA200100276A1 (ru) 2001-10-22
EA006501B1 (ru) 2005-12-29
EA200501461A1 (ru) 2006-02-24
JP4704565B2 (ja) 2011-06-15
AU772172B2 (en) 2004-04-08
KR20010085838A (ko) 2001-09-07
JP2002526062A (ja) 2002-08-20
NO20011460L (no) 2001-05-23
ES2329741T3 (es) 2009-11-30
EP2105446B1 (en) 2013-08-14
IL142164A (en) 2009-09-22
HUP0103593A2 (hu) 2002-01-28
NO20011460D0 (no) 2001-03-22
CN1344320A (zh) 2002-04-10
PL349068A1 (en) 2002-07-01
EA014417B1 (ru) 2010-12-30
IL142164A0 (en) 2002-03-10
DE69941126D1 (de) 2009-08-27

Similar Documents

Publication Publication Date Title
DE69930846D1 (de) Mehrkonfiguration-rückwand
NO20005508D0 (no) Adenosin-A3-reseptormodulatorer
GB9912350D0 (en) Modified cytokine
NO20005215D0 (no) Dihydropyrimidiner
IL185764A0 (en) Antibody to cytokine receptor zalpha11
IT1294332B1 (it) Seggiolone regolabile
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
DE69910462D1 (de) Cervicalorthese
DE69901430T2 (de) Zentriereinrichtung
DE59906732D1 (de) Verstellmechanismus
NO20013997L (no) Reseptoranalyse
DE69840421D1 (de) Teilnehmerkontextes
BR9708846A (pt) Dispositivo de regulação
FR2782671B3 (fr) Livre
DE59906606D1 (de) Lösbare verbindungsanordnung
DE29704960U1 (de) Einstellvorrichtung
DE29802218U1 (de) Verstellbarer Spannkeil
IL140987A0 (en) Orphan cytokine receptor
DE59800595D1 (de) Verstellbarer anschlag
DE29716075U1 (de) Verstellvorrichtung
DE29704944U1 (de) Fußbank
DE29719137U1 (de) Höhenverstellbare Armlehne
DE29722853U1 (de) Fußkeil
DE29807683U1 (de) Justiervorrichtung
ITAR980023A1 (it) Dispositivo segnaposto